# OnCo record minghui-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/minghui-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "minghui-pharmaceutical" ;
  schema:name "Minghui Pharmaceutical"@en ;
  schema:alternateName "Minghui Pharmaceutical (Hangzhou) Ltd"@en ;
  schema:description "Minghui Pharmaceutical is a China-based biotechnology company that leads 9 cancer trials in OnCo, testing its MHB-series antibody-drug conjugates and the bispecific antibody MHB039A in prostate cancer and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/minghui-pharmaceutical/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?lead=Minghui%20Pharmaceutical%20(Hangzhou)%20Ltd> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/furmonertinib/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/mhb039a/>, <https://onco.cc/drugs/mhb036c/>, <https://onco.cc/drugs/qlc5508/> ;
  onco:trials <https://onco.cc/trials/nct07326488/>, <https://onco.cc/trials/nct07229599/>, <https://onco.cc/trials/nct07130383/>, <https://onco.cc/trials/nct06373406/>, <https://onco.cc/trials/nct06345482/>, <https://onco.cc/trials/nct07192107/>, <https://onco.cc/trials/nct06985355/>, <https://onco.cc/trials/nct07192120/>, <https://onco.cc/trials/nct07126665/> .